N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia

Farokhnia, Mehdi; Azarkolah, Anita; Adinehfar, Forod; Khodaie-Ardakani, Mohammad-Reza; Hosseini, Seyed-Mohammad-Reza; Yekehtaz, Habibeh; Tabrizi, Mina; Rezaei, Farzin; Salehi, Bahman; Sadeghi, Seyed-Mohammad-Hossein; Nakhai Moghadam, M; Gharibi, Fardin; Mirshafiee, Omid; Akhondzadeh, Shahin

doi:10.1097/wnf.0000000000000001

Public

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia

Published in Clinical Neuropharmacology • Nov 1, 2013

Authors:

Mehdi Farokhnia

Anita Azarkolah

Forod Adinehfar

Abstract

OBJECTIVES: Despite the burden of negative symptoms on quality of life in schizophrenic patients, no completely effective treatment has been developed to address such symptoms yet. Abnormalities in oxidative stress pathways have been recently demonstrated to be involved in the pathophysiology of sch...

Subject

Risperidone

Schizophrenia (object-oriented programming)

Positive and Negative Syndrome Scale

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!